Form4insider filings, from the source

SEC Form 4 · accession 0000919574-17-008352

Recro Pharma, Inc. · REPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin Kotler
10% Owner
Period of report
Nov 21, 2017
Accepted (ET)
Nov 24, 2017 · 1:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.01 par value per shareF1Nov 21, 2017S100,000$9.50D3,000,086D
Common Stock, $0.01 par value per shareF1Nov 21, 2017S2,440$9.37D2,997,646D
Common Stock, $0.01 par value per shareF1Nov 22, 2017S48,566$9.37D2,949,080D
Common Stock, $0.01 par value per shareF1Nov 22, 2017S3,088$9.36D2,945,992D
Common Stock, $0.01 par value per shareF1Nov 24, 2017S2,913$9.32D2,943,079D
Common Stock, $0.01 par value per shareF1Nov 24, 2017S2,051$9.31D2,941,028D
Common Stock, $0.01 par value per shareF1Nov 24, 2017S5,800$9.39D2,935,228D
Common Stock, $0.01 par value per shareF1Nov 24, 2017S1,450$9.48D2,933,778D
Common Stock, $0.01 par value per shareF1Nov 24, 2017S5,900$9.37D2,927,878D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses